We are live on ! Find out more
GNPX icon

Genprex

15 hedge funds and large institutions have $165K invested in Genprex in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,170% more capital invested

Capital invested by funds: $13K → $165K (+$152K)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

67% more funds holding

Funds holding: 915 (+6)

0.12% more ownership

Funds ownership: 0.01%0.14% (+0.12%)

Holders
15
Holders Change
+6
Holders Change %
+66.67%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
1
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$2
TRCT
27
Tower Research Capital (TRC)
New York
-$5.74K -149 Closed
MWA
28
Miller Wealth Advisors
Colorado
-$2.1K -55 Closed
Bank of America
29
Bank of America
North Carolina
-$31 -1 Closed
Fidelity Investments
30
Fidelity Investments
Massachusetts
-$5

GNPX Hedge Fund Activity: Q1 2026 in Review

15 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2026, worth a combined $165K — up 1,170% from $13K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNPX positions and 4 closed out — a net gain of 6 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $72.2K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.74K sold.

  • 15 institutional investors held Genprex (GNPX) as of Q1 2026, up from 9 in Q4 2025.
  • Funds reported $165K of Genprex stock for Q1 2026, up 1,170% quarter-over-quarter.
  • 10 funds opened new Genprex positions in Q1 2026 and 4 closed out, a net change of +6 holders.
  • The largest Genprex buyer in Q1 2026 was Geode Capital Management, an estimated $72.2K added.
  • The largest Genprex seller in Q1 2026 was Tower Research Capital (TRC), an estimated $5.74K sold.

Based on aggregated 13F filings for Q1 2026.